567 POSTER Efficacy of BIBW 2992, an irreversible dual EGFR/HER2 receptor tyrosine kinase inhibitor, in combination with cytotoxic agents
- 30 November 2006
- journal article
- abstracts
- Published by Elsevier BV in European Journal of Cancer Supplements
- Vol. 4 (12), 172
- https://doi.org/10.1016/s1359-6349(06)70572-9